Adriana Correa

1.4k total citations
32 papers, 1.1k citations indexed

About

Adriana Correa is a scholar working on Molecular Medicine, Endocrinology and Molecular Biology. According to data from OpenAlex, Adriana Correa has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Medicine, 12 papers in Endocrinology and 9 papers in Molecular Biology. Recurrent topics in Adriana Correa's work include Antibiotic Resistance in Bacteria (30 papers), Pharmaceutical and Antibiotic Environmental Impacts (7 papers) and Bacterial biofilms and quorum sensing (7 papers). Adriana Correa is often cited by papers focused on Antibiotic Resistance in Bacteria (30 papers), Pharmaceutical and Antibiotic Environmental Impacts (7 papers) and Bacterial biofilms and quorum sensing (7 papers). Adriana Correa collaborates with scholars based in Colombia, United States and Argentina. Adriana Correa's co-authors include María Virginia Villegas, John P. Quinn, Jaime Alberto López, Karen Lolans, Juan Nicolás Kattán, Marta Vallejo, Carlos J. Suarez, Federico Pérez, María Camila Montealegre and Elsa De La Cadena and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Adriana Correa

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana Correa Colombia 16 935 376 285 238 236 32 1.1k
Evangelia Voulgari Greece 18 1.2k 1.3× 564 1.5× 248 0.9× 203 0.9× 264 1.1× 24 1.3k
Panagiota Giakkoupi Greece 20 1.3k 1.3× 547 1.5× 227 0.8× 282 1.2× 280 1.2× 36 1.3k
Katerina Themeli-Digalaki Greece 14 1.1k 1.2× 427 1.1× 284 1.0× 140 0.6× 226 1.0× 17 1.2k
Alessandro Capone Italy 17 838 0.9× 253 0.7× 241 0.8× 181 0.8× 150 0.6× 25 1.0k
N Mariano United States 8 1.2k 1.3× 452 1.2× 275 1.0× 216 0.9× 224 0.9× 9 1.3k
Alma Brolund Sweden 13 999 1.1× 478 1.3× 170 0.6× 169 0.7× 254 1.1× 18 1.1k
Yanyan Hu China 18 772 0.8× 276 0.7× 124 0.4× 292 1.2× 245 1.0× 49 1.0k
Verónica Bautista Spain 17 853 0.9× 458 1.2× 121 0.4× 206 0.9× 228 1.0× 24 1.0k
Recep Öztürk Türkiye 9 711 0.8× 335 0.9× 150 0.5× 278 1.2× 137 0.6× 12 819
Alina Iovleva United States 13 735 0.8× 263 0.7× 189 0.7× 149 0.6× 147 0.6× 26 876

Countries citing papers authored by Adriana Correa

Since Specialization
Citations

This map shows the geographic impact of Adriana Correa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Correa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Correa more than expected).

Fields of papers citing papers by Adriana Correa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Correa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Correa. The network helps show where Adriana Correa may publish in the future.

Co-authorship network of co-authors of Adriana Correa

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Correa. A scholar is included among the top collaborators of Adriana Correa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Correa. Adriana Correa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Correa, Adriana, et al.. (2024). Genomic Differences Associated with Resistance and Virulence in Pseudomonas aeruginosa Isolates from Clinical and Environmental Sites. Microorganisms. 12(6). 1116–1116. 5 indexed citations
4.
Rivera, Sandra, et al.. (2022). Beta-Lactam-Resistant Enterobacterales Isolated from Landfill Leachates. Pathogens. 11(10). 1077–1077. 2 indexed citations
5.
Cadena, Elsa De La, María F. Mojica, Cristhian Hernández-Gómez, et al.. (2022). Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries. Antibiotics. 11(8). 1101–1101. 5 indexed citations
6.
Mojica, María F., Elsa De La Cadena, Cristhian Hernández-Gómez, et al.. (2020). Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa. Journal of Global Antimicrobial Resistance. 21. 391–395. 23 indexed citations
8.
Mojica, María F., et al.. (2020). Evaluation of Allplex™ Entero-DR assay for detection of antimicrobial resistance determinants from bacterial cultures. BMC Research Notes. 13(1). 154–154. 2 indexed citations
10.
Mojica, María F., Rafael Ríos, Elsa De La Cadena, et al.. (2019). 612. Molecular Mechanisms Leading to Ceftolozane–Tazobactam Resistance in Clinical Isolates of Pseudomonas aeruginosa from Five Latin American Countries.. Open Forum Infectious Diseases. 6. 1 indexed citations
11.
Gutiérrez, Sergio, Adriana Correa, Cristhian Hernández-Gómez, et al.. (2019). Detection of carbapenemase-producing Pseudomonas aeruginosa: Evaluation of the carbapenem inactivation method (CIM). Enfermedades Infecciosas y Microbiología Clínica. 37(10). 648–651. 8 indexed citations
12.
Rosso, Fernando, et al.. (2019). Emerging carbapenem-resistant Aeromonas spp. infections in Cali, Colombia. The Brazilian Journal of Infectious Diseases. 23(5). 336–342. 25 indexed citations
13.
Correa, Adriana, Rosa del Campo, Kevin Escandón-Vargas, et al.. (2017). Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals. Microbial Drug Resistance. 24(1). 48–54. 31 indexed citations
14.
Cadena, Elsa De La, Adriana Correa, Juan Sebastián Muñoz, et al.. (2017). Molecular characterisation of carbapenem-resistant Enterobacter cloacae complex in Colombia: bla KPC and the ‘changing landscape’. Journal of Global Antimicrobial Resistance. 13. 184–189. 11 indexed citations
15.
Rosso, Fernando, et al.. (2017). Emerging Carbapenem-Resistant Aeromonas Infections in Cali, Colombia. Open Forum Infectious Diseases. 4(suppl_1). S131–S131. 1 indexed citations
16.
Cuzon, Gaëlle, Thierry Naas, Adriana Correa, et al.. (2013). Dissemination of the KPC-2 carbapenemase in non-Klebsiella pneumoniae enterobacterial isolates from Colombia. International Journal of Antimicrobial Agents. 42(1). 59–62. 18 indexed citations
17.
López, Jaime Alberto, Adriana Correa, Shiri Navon‐Venezia, et al.. (2010). Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clinical Microbiology and Infection. 17(1). 52–56. 59 indexed citations
18.
Villegas, María Virginia, Karen Lolans, Adriana Correa, et al.. (2007). First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase. Antimicrobial Agents and Chemotherapy. 51(4). 1553–1555. 235 indexed citations
19.
Villegas, María Virginia, Adriana Correa, Federico Pérez, et al.. (2004). CTX-M-12 β-Lactamase in a Klebsiella pneumoniae Clinical Isolate in Colombia. Antimicrobial Agents and Chemotherapy. 48(2). 629–631. 52 indexed citations
20.
Villegas, María Virginia, et al.. (2004). Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagnostic Microbiology and Infectious Disease. 49(3). 217–222. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026